Helen Sabzevari
President and CEO of Precigen, a biopharmaceutical company specializing in developing treatments for immuno-oncology, autoimmune disorders, and infectious diseases. Leading the development of innovative adenovirus-based therapies.
Best podcasts with Helen Sabzevari
Ranked by the Snipd community
Jan 30, 2025 • 27min
The Future of Adenovector-Based Therapies with Precigen's Helen Sabzevari, Ph.D.
Helen Sabzevari, Ph.D., President and CEO of Precigen, shares insights on innovative adenovirus-based therapies. She discusses the promising use of gorilla adenovectors, which enhance the delivery of large genetic payloads for effective gene therapies. Sabzevari reveals exciting results from Precigen's recent BLA submission, with over 50% of patients achieving Complete Response in pivotal studies. She also highlights the company's groundbreaking work in treating recurrent respiratory papillomatosis and the potential for broad applications in immuno-oncology and beyond.
Nov 16, 2023 • 38min
FDIC Deposits and Media Overview
Herman Chan discusses FDIC's plan for refilling deposit insurance funds. Dr. Helen Sabzevari talks about drug development for weight loss, cancer, and health treatments. Brian Stelter discusses his book 'Network of Lies.' Laura Martin shares her bearish outlook on Meta stock, Apple, and Disney.
